News

Business Insider4y
AC Immune Initiates IND-Enabling Studies for First-in-Class Antibody Targeting TDP-43 to Treat Neurodegeneration - Markets Insider
First-in-class TDP-43 antibodydeveloped using SurpraAntigen™ platform The only TDP-43 antibody with reported in vivo activity LAUSANNE, Switzerland, Aug. 03, 2020 (GLOBE NEWSWIRE) -- AC Immune ...
Business Insider5y
Ecolomondo hosts its groundbreaking ceremony in Hawkesbury for the construction of its new TDP turnkey facility - Markets Insider
/NOT FOR DISTRIBUTION TO U.S NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ MONTREAL, Aug. 28, 2019 /CNW Telbec/ - EcolomondoCorporation (TSXV: ECM) (the "Company" or "Ecolomondo ...
Business Wire2y
Ecolomondo Announces the Beginning of Production Ramp-Up at Its New Hawkesbury TDP Facility - Business Wire
The Company tested these changes last week with a batch of 4,000 lbs with Reactor 2 and results were very positive. On a technical perspective, both Reactor 1 and 2 have now performed successful ...
Business Wire1y
Ecolomondo Receives TSSA Certification for the Use of Process Gas as Energy Source for Its TDP Reactors - Business Wire
About the Shamrock Project – A 6-Reactor TDP Facility Processing capabilities for the Shamrock facility is projected at 42,000 metric tons per year of end-of-life tires, yielding approximately ...
Nasdaq4y
AC Immune to Present New Data from Alpha-Synuclein and TDP-43 Programs at the AD/PD™ 2021 Virtual Conference - Nasdaq
--AC Immune SA, a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced that four new data presentations will be ...